National Institutes of Health announced the discontinuation of clinical testing of hydroxychloroquine

category:Internet
 National Institutes of Health announced the discontinuation of clinical testing of hydroxychloroquine


The U.S. Food and Drug Administration canceled the emergency authorization for the use of hydroxychloroquine and chloroquine in the treatment of patients with new coronavirus infection on the 15th, on the grounds that there is increasing evidence that these two traditional anti malarial drugs are not effective against new coronavirus.

Source: Ding Guangsheng, editor in charge of Beijing News_ NT1941